Skip to main content
editorial
. 2023 Dec 24;9(3):516–519. doi: 10.1016/j.ekir.2023.11.029

Figure 1.

Figure 1

Map depicting the global distribution of median income or consumption per day (2019), and examples of monthly costs of SGLT2 inhibitors (converted to current US dollars) across Africa. It is clear that many patients across Africa would struggle to afford SGLT2i out of pocket. Cost data obtained through personal communication as of November 2023 with the following: Dr. Gordana Cavric (Botswana), Dr. Yewondwossen Tadasse Mengistu (Ethiopia), Dr. Thandiwe Dlamini (Eswatini), Dr Elliot K. Tannor (Ghana), Dr. Tea Weu Mélanie (Ivory Coast), Dr. Tarik Sqalli (Morocco), Dr. Ogo Egbuna (Nigeria), Dr. Claudia L. Do Vale (South Africa), Dr. Mahzar Amirali (Tanzania), Dr. Kossi Sabi (Togo), Prof Faical Jarraya (Tunisia), and Dr. Grace Kansiime (Uganda). Costs in USA (Prof Rasheed A. Balogun) and India (Prof Manisha Sahay) are included for comparison. Map reproduced from Joe Hasell, Max Roser, Esteban Ortiz-Ospina, and Pablo Arriagada (2022) - “Poverty” Published online at OurWorldInData.org. Retrieved from: 'https://ourworldindata.org/poverty'